Cargando…

Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review

With the development of evidence-based medicine, clinical trials have become necessary for investigating and validating the efficacy of new treatments. Over the past 10 years, several clinical trials of new anticancer agents have been designed and launched in China; this has greatly promoted the dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Shan, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547513/
https://www.ncbi.nlm.nih.gov/pubmed/28784178
http://dx.doi.org/10.1186/s13045-017-0514-z